LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, provided an update on its attendance at HLTH Europe 2026, a leading healthcare innovation conference held in June. Management reported that the event enabled direct engagement with healthcare innovators, technology companies, providers, insurers, and digital health organizations from Europe, Latin America, and other international markets, increasing awareness of LataMed's developing healthcare technology platform.
The Company noted that the conference reinforced management's belief that healthcare systems increasingly require integrated digital solutions capable of improving patient accessibility, care coordination, financial accessibility, and operational efficiency. Growing interest was observed across the healthcare sector in artificial intelligence applications, telehealth infrastructure, healthcare payments, insurance accessibility initiatives, and technology-enabled patient engagement solutions.
According to management, many themes discussed at HLTH Europe align closely with LataMed's ongoing efforts to develop an integrated healthcare ecosystem that combines telehealth infrastructure, healthcare coordination technologies, payment accessibility initiatives, insurance integration opportunities, pharmacy-related services, and AI-driven healthcare solutions. The conference provided valuable opportunities to exchange ideas with industry participants, evaluate emerging healthcare technology trends, and identify potential collaboration opportunities that may support the Company's long-term healthcare platform strategy.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “HLTH Europe provided an outstanding opportunity to engage with healthcare and technology professionals from across Europe, Latin America, and other international markets. One of the most encouraging takeaways from the conference was the growing industry focus on integrated healthcare platforms that combine accessibility, coordination, financial solutions, and technology-enabled patient engagement. We believe many of these trends align closely with the direction of our broader healthcare ecosystem strategy and reinforce our long-term vision for LataMed AI. The conference also provided valuable visibility for our platform initiatives and an opportunity to establish new industry relationships that may support our future growth objectives.”
The Company stated that it is currently reviewing and evaluating various follow-up opportunities resulting from discussions held during the conference and intends to provide additional updates regarding any material developments as appropriate. Photographs and highlights from the Company's attendance at HLTH Europe 2026 are available through LataMed AI's official Instagram page. For additional information, visit https://latamed.ai or review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
